10% Off
10% Off
marketed by MYLAN PAHARMACEUTICALS PVT.LTD
• 10TAB
₹225.00
M.R.P.: ₹250
10% Off
Inclusive of all taxes
Mprila tablet is a phosphodiesterase inhibitor. It works by blocking the action of certain chemical messengers, which is responsible for inflammation associated with plaque psoriasis. Hence, it reduces the signs and symptoms of psoriasis. You are advised to take dose and duration as prescribed by your doctor. Do not take more or less than the recommended dose. Medication must not be stopped unl
Hypersensitivity Pregnancy.
Babies: Not applicable.
Lactating mother: Consult your doctor before taking this medication during breastfeeding.
Pregnancy: Mprila tablet is not safe to take during pregnancy.
Some limited human and animal studies suggest that this drug may cause harmful effects on developing babies.
Consult your doctor.
Alcohol: Caution is advised when consuming alcohol with this medication.
Driving: Mprila tablet safe to use while driving.
Kidney: Mprila tablets must be used with caution in patients with severe kidney disease.
Dose adjustment is required.
Consult your doctor.
Liver: Mprila tablet is safe to use if prescribed by your doctor in patients with liver disease.
Dose adjustment is not required.
.
Diarrhea Nausea Vomiting.
Mprila tablet is a phosphodiesterase inhibitor.
It works by blocking the action of certain chemical messengers, which is responsible for inflammation associated with plaque psoriasis.
Hence, it reduces the signs and symptoms of psoriasis..
If you miss a dose, take it as soon as possible.
If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily.
Don't double the dose to catch up with the missed dose..
• Mprila tablet is used in the treatment of plaque psoriasis. • This medication may cause stomach upset during the early treatment. • Mprila tablet may cause weight loss; check your weight while taking this medication. • Consult your doctor if you notice or experience any changes in your mood, depression, or suicidal thoughts, and unexplained weight loss. .
• Mprila + Carbamazepine: Concurrent use may result in decreased mprila exposure • Mprila + Enzalutamide: Concurrent use may result in decreased mprila exposure • Mprila + Fosphentoin: Concurrent use may result in decreased mprila exposure • Mprila + Mitotane: Concurrent use may result in decreased mprila exposure • Mprila + Rifabutin: Concurrent use may result in decreased mprila exposure.
100% Authentic
Easy Return